Video

Why Is Community Engagement Key To Increasing Patient Diversity?

Source: Clinical Leader
20_11_CLL_PatientDiversity_1920x1080_Clip2

Patient diversity remains a problem in clinical trials. Although FDA-approved medicines serve a diverse population of Americans, participation in clinical trials remains predominantly white and male. There is a lot that still needs to be done to increase the enrollment of minority populations in clinical trials. 

In this webinar segment, RADM Richardae Araojo, associate commissioner for minority health and director of the Office of Minority Health and Health Equity, discusses community engagement and why it is critical to patient recruitment. Community engagement helps sponsor companies overcome barriers that exist and raises awareness of trials in non-white communities. Araojo also discusses some successful strategies companies have used to increase patient diversity in their trials.

VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: